Loading viewer...
investor_presentation
Format: PDF investor_presentation
Perrigo's February 2023 strategic offsite presentation outlining Phase 2 of its optimization and acceleration initiatives. The company addresses supply chain reinvention, recent acquisitions including HRA Pharma, and regulatory developments such as OTC oral contraceptive approvals, amid broader economic and geopolitical headwinds.
investor_presentation
24 Pages
Calibre Mining
investor_presentation
Linamar
Xenon Pharmaceuticals Investor Presentation — May 2022
investor_presentationinvestor_presentation
19 Pages
Xenon Pharmaceuticals Inc.